Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
530.00    5.00 (0.95%)
Bid:
524.00
Ask:
531.00
Spread: 7.00 (1.336%)
Market Cap: £304.98m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Statement

24 May 2023 07:00

RNS Number : 4155A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"In an ongoing challenging environment, we continue to demonstrate the strength of MAB's model and resilience in adviser numbers and mortgage completions against a significantly weaker market backdrop. This positions the Group well for subsequent market recovery.

"Our Adviser numbers have stabilised in Q2 at 2,1221 advisers on 19 May 2023. We expect our existing Appointed Representative firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves further when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty. Our pipeline of incoming new Appointed Representatives has grown strongly this year.

"As expected, the value of completions in the wider market was slower in Q1 2023 with a 21% reduction in new mortgage lending2 compared to last year. MAB's total mortgage completions for Q1 2023 were broadly stable at £5.8bn (2022: £5.9bn). Our new mortgage completions were £4.4bn (2022: £4.9bn) with the balance of £1.4bn (2022: £1.0bn) being Product Transfers. We have continued to grow our market share, which has been achieved despite a reduction in the number of advisers since Q4 2022.

"During the six months following the mini-budget, new mortgage approvals across the market were down by as much as 40% versus the prior year. There are early signs of increasing activity and mortgage approval levels have now gradually started to improve, but remain significantly lower than for the equivalent period last year.

"MAB's performance, despite challenging market conditions, remains in line with the Board's expectations with further improvement expected in the second-half of the year."

 

1 Includes 139 Fluent advisers as at 19 May 2023 (76 advisers in the first charge mortgages division, 49 in the secured personal loans division, 8 in the later life division, and 6 in the bridging finance division). Includes a total of 183 advisers at 19 May 2023 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 UK Finance, product transfer lending figures not available until 7 June.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFWDEDSEEI
Date   Source Headline
4th Feb 20257:00 amRNSBusiness Update
31st Jan 20253:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
15th Jan 202512:06 pmRNSDirector/PDMR Shareholding
14th Jan 20253:09 pmRNSBlock listing Interim Review
13th Jan 20259:19 amRNSHolding(s) in Company
31st Dec 202411:56 amRNSDirector/PDMR Shareholding
17th Dec 202411:40 amRNSDirectors' Shareholdings and PDMR notification
2nd Dec 202411:40 amRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSDirector/PDMR Shareholding
14th Nov 202411:09 amRNSDirector/PDMR Shareholding
13th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20247:00 amRNSNotice of Capital Markets Day
12th Nov 20249:14 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSAppointment of Nominated Adviser and Joint Broker
4th Nov 20249:09 amRNSDirectors' Shareholdings and PDMR notification
28th Oct 20249:43 amRNSNotification of Major Holdings
15th Oct 20242:47 pmRNSDirectors' Shareholdings and PDMR notification
4th Oct 202412:16 pmRNSDirectors' Shareholdings and PDMR Notification
2nd Oct 20245:15 pmRNSNotification of Major Holdings
30th Sep 20244:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Sep 202411:58 amRNSDirectors' Shareholdings and PDMR notification
30th Sep 20249:42 amRNSDirectors' Shareholdings and PDMR notification
25th Sep 20247:00 amRNSDirectors' Shareholdings and PDMR notification
24th Sep 20247:00 amRNSInterim Results
17th Sep 20241:44 pmRNSDirectors' Shareholdings and PDMR notification
17th Sep 20249:16 amRNSNotification of Major Holdings
30th Aug 20245:17 pmRNSDirectors' Shareholdings and PDMR notification
15th Aug 20243:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Jul 20245:35 pmRNSDirectors' Shareholdings and PDMR notification
25th Jul 20247:00 amRNSTrading Update
22nd Jul 20248:02 amRNSDirectors' Shareholdings and PDMR notification
22nd Jul 20247:00 amRNSDirectors' Shareholdings and PDMR notification
12th Jul 20241:19 pmRNSBlock listing Interim Review
1st Jul 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20241:57 pmRNSNotification of Major Holdings
25th Jun 20247:00 amRNSNotification of Major Holdings
21st Jun 20243:06 pmRNSNotification of Major Holdings
17th Jun 20245:49 pmRNSDirector/PDMR Shareholding
13th Jun 202412:39 pmRNSDirector/PDMR Shareholding and TVR
12th Jun 20244:46 pmRNSNotification of Major Holdings
4th Jun 20244:18 pmRNSNotification of Major Holdings
31st May 202410:36 amRNSDirectors' Shareholdings and PDMR notification
29th May 20247:00 amRNSRelated Party Transaction
28th May 20243:56 pmRNSNotification of Major Holdings
23rd May 20247:00 amRNSResult of AGM
22nd May 20247:00 amRNSAGM Statement
17th May 20243:26 pmRNSNotification of Major Holdings
14th May 20244:37 pmRNSDirectors' Shareholdings and PDMR notification
10th May 20247:00 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.